Ironwood initiates apraglutide NDA submission
Pharmaceuticals announced a streamlined strategic focus on advancing and realizing the potential of apraglutide for the ...
Hosted on MSN1d
Auditor says the state’s settlement agreement policies need overhaul
State Auditor Diana DiZoglio released an audit of settlement agreements and confidentiality clauses across state agencies and ...
Mass. officials used confidentiality clauses in dozens of settlements despite supposed NDA ban, audit finds
State Auditor Diana DiZoglio on Tuesday charged that Massachusetts is relying on a “broken system” for both executing and ...
HR Dive2d
Nearly half of employees say they’re subject to an NDA
Restrictive covenants could limit workers’ ability to report discrimination and harassment, two Lift Our Voices studies ...
Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Accepts FDA Opportunity for a Hearing on New Drug Application for Tradipitant in Gastroparesis
Highlights faulty FDA review WASHINGTON, Jan. 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provides an update on the tradipitant ...
Pharmaceutical Technology6d
Stealth faces another hurdle as FDA delays decision on Barth syndrome drug
The FDA rejected the company’s initial NDA in 2021, citing the lack of an adequate trial to demonstrate efficacy.